Citigroup's Buy recommendation and pending earnings support a positive fundamental outlook despite recent price slides. Technical indicators suggest consolidation before a potential breakout.

Market sentiment remains bullish with multiple buy recommendations outweighing recent concerns about share price slides. Analysts consistently highlight ZTS as a strong healthcare stock to consider.

While short-term volatility exists from earnings uncertainty and price slides, long-term fundamentals remain solid in the animal health sector. The consistent buy recommendations from analysts provide a safety net for long-term holders.

Recent price action shows ZTS underperforming the broader market, but volume patterns indicate accumulation rather than distribution. Technical signals from pending earnings and analyst coverage suggest a neutral-to-bullish setup.